فهرست مطالب

Cancer Management - Volume:11 Issue: 9, Sep 2018

International Journal of Cancer Management
Volume:11 Issue: 9, Sep 2018

  • تاریخ انتشار: 1397/07/23
  • تعداد عناوین: 7
|
  • Mohammad Hasan Soheilifar , Abdolvahab Moshtaghian , Hamid Maadi , Fereshteh Izadi , Massoud Saidijam * Page 1
    Context: Colorectal cancer (CRC) is among the most common cancers in the world. Despite the existence of different treatment strategies such as chemoradiation and surgery, CRC therapy still remains a significant challenge as a result of the existence of cancer stem cells (CSCs). Evidence Acquisition: This review is comprised of research and review studies published in valid databases such as PubMed, ScienceDirect, Medline, Google Scholar, and Scopus, using the following keywords: BMI1, cancer stem cell, microRNA, and colorectal cancer.
    Results
    BMI1 (B cell-specific Moloney murine leukemia virus integration site 1) is a key component of polycomb repressor complex 1 (PRC1) and plays a significant role in CSCs self-renewal in various types of cancer including CRC. It has been proven that BMI1, in association with deregulated microRNAs (miRNAs), can promote cell cycle progression as well as epithelial to mesenchymal transition (EMT) in cancer.
    Conclusions
    BMI1 is a colon stem cell marker that is up-regulated in colon CSCs and can be taken as a promising target for CRC therapy. This review describes the role of BMI-1 in the self-renewal of CSCs and EMT in association with miRNA dysregulation (with emphasis on CRC).
    Keywords: BMI1, Cancer Stem Cell, miRNA, Colorectal Cancer
  • Hamidreza Mirzaei , Parisa Sabetrasekh , Parto Sabetrasekh , Mahmoud Parvin , Peyman Torbati , Parastoo Hajian * Page 2
    Background
    Tumor growth, invasion, and metastasis are angiogenesis dependent; so, using anti-angiogenic therapies can block these procedures. Vascular endothelial growth factor (VEGF) is a strong proangiogenic factor that is expressed by many cancer cells like bladder cancer.
    Objectives
    The aim of this study was to determine the prevalence of the VEGFR in transitional cell carcinoma (TCC) of bladder and its relationship with other prognostic factors.
    Methods
    This cross sectional study was carried out on 61 patients with TCC of bladder after radical cystectomy (RC). These patients were referred to the Urology Ward in Labbafineazhad Hospital in Tehran, Iran. The relationship of VEGF and the prognostic factors was determined, using the Fisher's Exact and Chi-square for data analyzing by SPSS software version 17.
    Results
    Among 61 patients with TCC of bladder, only 8 patients (13.1%) were VEGFR positive, and there was no significant relation between frequency of VEGFR expression and the other factors like age, gender, stage, lymph node involvement, lymphovascular, or perineural space invasion.
    Conclusions
    According to this study, the most patients with TCC of bladder did not express VEGFR; also, none of the prognostic factors showed any relation with VEGFR expression.
    Keywords: Vascular Endothelial Growth Factor Receptor, Prognostic Factors, Transitional Cell Carcinoma
  • Elham Taeidi , Simmin Montazeri*, Nasser Behroozi , Mohammad Hosein Haghighy Zadeh , Ahmad Ahmadzadeh Deilami Page 3
    Background
    Women with breast cancer experience major problems. One counseling method improving mental health is problem solving therapy (PST). Since psychological wellbeing is a measure of mental health, individuals with poor psychological wellbeing are subject to depression and anxiety. Therefore, improvement of psychological wellbeing results in physical and mental health.
    Objectives
    The purpose of this study is to investigate the effect of problem solving therapy on the psychological wellbeing of women with breast cancer.
    Methods
    This clinical trial was performed on 34 women affected with breast cancer. Convenience sampling was employed to collect samples in Shafa Specialty Hospital of Ahvaz, Iran (2017). Patients were randomly assigned into intervention (n = 17) and control group (n = 17). Problem solving therapy was applied in 8 ninety-minute sessions weekly. The Data were gathered using the demographic questionnaire and Ryff 's psychological wellbeing questionnaire, including 84 items. In a one-month follow-up study, the patients filled in Ryff’s psychological wellbeing questionnaire again.
    Results
    The results of investigating the effect of group problem solving therapy on psychological wellbeing revealed that the average of psychological wellbeing of pretest, posttest and follow-up study of the weekly intervention group was 240.94 ± 4.84, 421 ± 11.11, and 429.52 ± 10.94, respectively. In fact, all scores showed an increase. However, the scores of the pretest and follow-up study of the control group showed no increase. The highest score belonged to environmental mastery dimension. The mean of environmental mastery of intervention group in pretest, posttest and follow-up study was 40.00 ± 4.18, 76.11 ± 2.54, and 77.05 ± 2.10, respectively. Therefore, problem solving therapy improves the psychological wellbeing of the patients (P < 0.05).
    Conclusions
    Problem Solving Therapy can be applied to improve psychological wellbeing of women with breast cancer.
    Keywords: Psychological Wellbeing, Problem Solving Therapy, Breast Cancer
  • Mehdi Azizmohammad Looha , Elaheh Zarean , Mohammad Amin Pourhoseingholi , Seyyed Vahid Hosseini , Tara Azimi , Soheila Khodakarim * Page 4
    Background
    Colorectal cancer (CRC) is a heterogeneous disease that occurs in different parts of the gastrointestinal system.
    Objectives
    This study aimed at analyzing the effects of risk factors on survival and cure fraction of patients with CRC in a population of Iranian patients, using parametric non-mixture cure rate model.
    Methods
    This retrospective cohort study was conducted at Shiraz University of Medical Sciences on 512 patients with CRC. Patients were followed-up for 8 years, from January 2009 until February 2017. Stepwise selection and parametric non-mixture cure rate model were used to find the risk factors of survival in patients with CRC. Akaike information criteria was used to identify the best parametric non-mixture cure rate model in this study.
    Results
    Staging III (OR = 0.41, 95% CI: 0.19 - 0.90, P = 0.026), staging IV (OR = 0.15, 95% CI: 0.04 - 0.50, P = 0.002), Perineural invasion (OR = 0.41, 95% CI: 0.21 - 0.92, P = 0.007), and lymph node ratio (OR = 0.94, 95% CI: 0.51 - 0.82, P = 0.002) had significant effects on cure fraction and survival of patients with CRC.
    Conclusions
    Perineural invasion, Lymph node ratio, and American Joint Committee on Cancer (AJCC) staging should be assessed as an important factor in modeling survival analysis of patients with CRC. Patients who were in advanced stages of CRC should have received treatment and appropriate therapies given their shorter survival rates.
    Keywords: Colorectal Neoplasms, Survival Analysis, Non-Mixture Cure Rate Models
  • Nematollah Rostami , Zohreh Maghsoomi *, Farzad Dashti Page 5
    Introduction
    One of the rare platelet dysfunction, which is impairment of receptor GPIIb/IIIa and platelet aggregation defect, is acquired Glanzmann’s thrombasthenia. A common cause of this thrombasthenia is an autoantibody or plasma protein inhibitor against a normal GPIIb/IIIa glycoprotein.
    Case Presentation
    In this case report, a 28-year-old female with a history of treated Hodgkin’s lymphoma presented with a menometrorrhagia and ecchymosis. Before that, she had no bleeding history and there was no family history bleeding tendency. Laboratory findings revealed bleeding time > 10 minutes, normal partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen, and von Willebrand factor. Platelet-aggregation studies showed no aggregation to adenosine diphosphate (ADP), collagen, and a normal response to ristocetin. The clinical history, medical history, and laboratory findings supported a diagnosis of acquired Glanzmann’s thrombasthenia. Imaging revealed significant lymph nodes was compatible with recurrent disease. The patient’s menorrhagia and bleeding tendency were controlled by systemic chemotherapy.
    Conclusions
    This report shows the association of acquired thrombasthenia with the recurrent Hodgkin’s lymphoma, which can be controlled by remission induction chemotherapy.
    Keywords: Glanzmann’s Thrombasthenia, Hodgkin’s Lymphoma, Acquired Thrombasthenia
  • Farzad Allameh , Samira Azghandi , Morteza Fallah Karkan * Page 7